Newer immunosuppressive drugs: their potential role in rheumatoid arthritis therapy

Drugs
Alexandros A Drosos

Abstract

Rheumatoid arthritis (RA) is a chronic immune-mediated disease characterised by chronic synovitis, which leads to cartilage damage and joint destruction. It is generally a progressive disease with radiographic evidence of joint damage, functional status decline and premature mortality. Proinflammatory cytokines, such as interleukin 1 and tumour necrosis factor alpha, play an important role in maintaining the chronicity of RA and mediating tissue damage. New approaches in the therapy of RA with anticytokine biological agents, which neutralise or block cytokines or their receptors, are now the first generation antirheumatic drugs in clinical practice. A better understanding of the signal transduction systems and gene regulation by transcription factors involved in cytokine production has opened the way for the discovery of novel therapeutic compounds useful in treating patients with RA. Overactivation of selective kinases or aberrant function of downstream transcription factors could help convert a normal immune response to a chronic disease state. This provides a unique opportunity for novel therapeutic interventions, since specific signal transduction or transcription factor targets might interrupt the perpetuation mechanisms i...Continue Reading

References

Feb 1, 1977·Canadian Journal of Physiology and Pharmacology·R R MartelS Galet
Oct 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·R O WilliamsR N Maini
Dec 10, 1991·Biochimica Et Biophysica Acta·P Angel, M Karin
Jun 1, 1991·Current Opinion in Rheumatology·G S Firestein
Jan 1, 1991·Transplantation·K P PlatzA C Allison
May 3, 1990·The New England Journal of Medicine·E D Harris
Jan 1, 1988·Clinical Immunology and Immunopathology·N InamuraM Kohsaka
Jul 1, 1969·The Biochemical Journal·T J Franklin, J M Cook
Apr 1, 1994·The Annals of Pharmacotherapy·M A Hooks
Jan 5, 1995·The New England Journal of Medicine·A G Papavassiliou
Jan 1, 1994·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·A MustW H Dietz
Jul 1, 1993·British Journal of Rheumatology·G S Panayi
Nov 1, 1995·Current Opinion in Nephrology and Hypertension·M E CardenasJ Heitman
Jun 1, 1996·Arthritis and Rheumatism·G PaseroO Della Casa-Alberighi
Jun 1, 1996·Current Opinion in Immunology·B Su, M Karin
Feb 1, 1996·Rheumatic Diseases Clinics of North America·D E Yocum
Oct 1, 1996·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·A J Whitmarsh, R J Davis
Apr 10, 1997·The New England Journal of Medicine·P J Barnes, M Karin
Apr 1, 1997·Nature Structural Biology·L TongC A Pargellis
May 1, 1997·Clinical Immunology and Immunopathology·M Odeh
Dec 31, 1998·Arthritis and Rheumatism·B BresnihanP Musikic
Jan 5, 1999·Bioorganic & Medicinal Chemistry Letters·J R HenryJ J Siekierka
Apr 22, 1999·Arthritis and Rheumatism·G S Firestein, A M Manning
Aug 24, 1999·Pharmacology & Therapeutics·J C LeeJ L Adams
Dec 22, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R I FoxB J Kirschbaum

❮ Previous
Next ❯

Citations

Jan 1, 2005·Rheumatology International·Paola CaramaschiLisa Maria Bambara
Mar 7, 2013·European Journal of Pharmacology·Cahide Elif OrhanSibel Ülker
Dec 24, 2002·Human Psychopharmacology
Jan 17, 2004·Biochimica Et Biophysica Acta·Sangita B PatelGiovanna Scapin
Jan 17, 2007·Expert Opinion on Biological Therapy·Paraskevi V Voulgari, Alexandros A Drosos
Mar 1, 2006·Expert Opinion on Investigational Drugs·Felix Braun, Matthias Behrend
Jul 31, 2013·The Veterinary Clinics of North America. Small Animal Practice·Katrina R Viviano
Nov 1, 2011·International Journal of Pharmaceutics·Kevin J KauffmanKristy M Ainslie
Dec 14, 2004·Joint, Bone, Spine : Revue Du Rhumatisme·Jacques Morel, Francis Berenbaum
Oct 15, 2005·Transplant Immunology·Anlun MaHuifang Chen
May 4, 2005·The American Journal of Medicine·Paraskevi V VoulgariAlexandros A Drosos
Jan 28, 2003·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Shawn D St PeterDavid C Mulligan
Dec 4, 2003·Expert Opinion on Pharmacotherapy·Titte R SrinivasHerwig Ulf Meier-Kriesche
Dec 13, 2006·International Immunopharmacology·Toshihiko Hirano
Dec 23, 2017·Bone Marrow Transplantation·Alvaro López-IñiguezJennifer Cuellar-Rodriguez
Nov 25, 2003·The Journal of Bone and Joint Surgery. American Volume·Howard AmitalAlan Rubinow
Nov 11, 2019·Advances in Rheumatology·Ricardo Machado XavierCesar Ramos-Remus
Oct 24, 2007·Thérapie·Anne-Sophie OngSiamak Davani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

The New England Journal of Medicine
J A Oates, A J Wood
Current Infectious Disease Reports
R Carreño-ManjarrezJ B Zabriskie
© 2022 Meta ULC. All rights reserved